CEO Commentaries

To transform an invention to a product that can be purchased by any scientist is the often unappreciated but crucial role of commercializing enterprises. This was the underlying theme of my presentation at SPIE 2018, “The evolution of Phase Holographic Imaging from a research idea to publicly traded company”.

The special issue and the increasing number of scientific publications by HoloMonitor customers, and others, leave no room for doubt. Label-free time-lapse cytometry has begun to fulfill its promise to medical science — a leap of understanding.

Metastases are believed to originate from a rare type of tumor cells known as cancer stem cells. A combined tool for identifying and studying rare cells would provide cancer researchers with new information to better under­stand the nature of cancer stem cells, and hopefully allow them to develop treatments against these rare and deadly cells.

To transform an invention to a product that can be purchased by any scientist is the often unappreciated but crucial role of commercializing enterprises. This was the underlying theme of my presentation at SPIE 2018, “The evolution of Phase Holographic Imaging from a research idea to publicly traded company”.

In our daily lives, we all know how important it is to plan ahead to avoid a future mess. Ironically, we ourselves are such a future mess.

Using HoloMonitor, scientists at Northeastern University have shown that paclitaxel-resistant ovarian cancer cells stopped multiplying by cell division when treated with nanoparticles. Ovarian cancer causes more deaths than any other cancer of the female reproductive system.